Orthostatic Intolerance After Bariatric Surgery

Summary

Orthostatic Intolerance After Bariatric Surgery is a clinical trial^[1].

Key Facts

• Orthostatic Intolerance After Bariatric Surgery is in the country of United States^[2].
• Orthostatic Intolerance After Bariatric Surgery's instance of is recorded as clinical trial^[3].
• Orthostatic Intolerance After Bariatric Surgery's start time is recorded as +2018-07-01T00:00:00Z^[4].
• Orthostatic Intolerance After Bariatric Surgery's end time is recorded as +2020-06-30T00:00:00Z^[5].
• Orthostatic Intolerance After Bariatric Surgery's sponsor is recorded as Vanderbilt University Medical Center^[6].
• Orthostatic Intolerance After Bariatric Surgery's number of participants is recorded as {'unit': '1', 'amount': '+45'}^[7].
• Orthostatic Intolerance After Bariatric Surgery's title is recorded as Orthostatic Intolerance After Bariatric Surgery^[8].
• Orthostatic Intolerance After Bariatric Surgery's short name is recorded as RYGB^[9].
• Orthostatic Intolerance After Bariatric Surgery's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[10].
• Orthostatic Intolerance After Bariatric Surgery's ClinicalTrials.gov ID is recorded as NCT03808740^[11].
• Orthostatic Intolerance After Bariatric Surgery's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+60'}^[12].
• Orthostatic Intolerance After Bariatric Surgery's research intervention is recorded as atomoxetine hydrochloride^[13].
• Orthostatic Intolerance After Bariatric Surgery's clinical trial phase is recorded as phase I clinical trial^[14].
• Orthostatic Intolerance After Bariatric Surgery's principal investigator is recorded as Cyndya A. Shibao^[15].
• Orthostatic Intolerance After Bariatric Surgery's study type is recorded as interventional study^[16].